The Chemours Company (NYSE:CC) Q3 2025 Earnings Call Transcript

Q3 2025 Earnings Call Transcript November 7, 2025 Operator: Good morning. My name is Gigi, and I’ll be your conference ...

Chemours anticipates double-digit Opteon growth and $5.7B–$5.8B sales in 2025 as TSS ...

Q3 2025 Management View Denise Dignam, President, CEO & Director, reported that "we exceeded our adjusted EBITDA expectations ...